Rabin Medical Center
Dr. Ursula Winterfeld is affiliated to From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey. , Rabin medical university. Dr. Ursula Winterfeld is currently providing services as Professor. Dr. Ursula Winterfeld has authored I145and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Ursula Winterfeld contributions have acclaimed recognition from honourable subject experts around the world. Dr. Ursula Winterfeld is actively associated with different societies and academies. Dr. Ursula Winterfeld academic career is decorated with several reputed awards and funding. Dr. Ursula Winterfeld research interests include .